Clinical Trial Update: Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase I/II clinical trial of TSU-68 for advanced hepatocellular carcinoma is summarized, conducted by Taiho Pharmaceutical.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TSU-68 (TSU-68)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: COMPLETED